{"id":"W2075213874","doi":"10.1056/nejmoa043681","title":"Adjuvant Docetaxel for Node-Positive Breast Cancer","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":952,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Health Economics; Sault Area Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Hôpital du Saint-Sacrement; Hôpital Saint-Luc; Nova Scotia Cancer Centre; Saskatchewan Cancer Agency; Ottawa Regional Cancer Foundation","funders":"Association of Medical Research Charities; Canadian Breast Cancer Research Alliance; GlaxoSmithKline; Amgen; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Docetaxel; Adjuvant; Breast cancer; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001826553,0.0001277191,0.0002601692,0.00004138961,0.00004739134,0.000003849485,0.00009874939,0.00004598685,0.00006109921],"category_scores_gemma":[0.00005249311,0.00008124684,0.00007433216,0.00003984035,0.00006738734,0.000005264534,0.00001947189,0.00007544683,0.000001092757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000388552,"about_ca_system_score_gemma":0.0001166941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008847919,"about_ca_topic_score_gemma":0.000148184,"domain_scores_codex":[0.9993004,0.00002202601,0.0002463761,0.0001199895,0.0001510873,0.000160181],"domain_scores_gemma":[0.9993172,0.00003511157,0.000186523,0.00009216683,0.0002402131,0.0001287972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003909689,0.0001387719,0.01384451,0.00002631547,0.0008941623,0.00002131064,0.0008952732,0.0002917261,0.05110537,0.00006001279,0.09755583,0.831257],"study_design_scores_gemma":[0.1410067,0.002423174,0.1517764,0.0006720122,0.001003591,0.00342656,0.0003993794,0.00005081622,0.03795931,0.0002842709,0.6605521,0.0004456292],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7451313,0.05164341,0.009875147,0.1886955,0.002008806,0.0004483245,0.0003308856,0.00001386781,0.001852738],"genre_scores_gemma":[0.9803736,0.001820069,0.001063235,0.001367666,0.01496804,0.000005885692,0.00001744237,0.0000150868,0.0003689698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8308114,"threshold_uncertainty_score":0.331315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009921351495374873,"score_gpt":0.2840717143014677,"score_spread":0.2741503628060928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}